BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

DATATRAK International, Inc. (DATA) CTO Elected as CDISC Advisory Board Chair-Elect


2/5/2013 6:54:51 AM

CLEVELAND, Feb. 5, 2013 /PRNewswire/ -- DATATRAK International, Inc. (OTCQX: DTRK), a leader in developing cloud-based, unified eClinical® technologies and delivering related services for the clinical trials industry, today announced Chris Wilke, DATATRAK's Chief Technology Officer, was elected as the CDISC Advisory Board's (CAB) Chair-Elect.

(Logo: http://photos.prnewswire.com/prnh/20130107/CL38347LOGO)

"We are very pleased to have Chris Wilke as a member of the CDISC Advisory Board's leadership team. His many years of industry experience will add immense value to this group and will further promote our vision to inform patient care and safety through higher quality medical research," said Dr. Rebecca Kush, President and CEO, CDISC.

"Standards are key to effective sharing of clinical research data and ultimately, improving patient health," stated Chris Wilke, DATATRAK's CTO. "After serving as a member of the Advisory Board for two years, I am excited to take a more active role in furthering CDISC's mission to develop and support global, platform-independent data standards."

As a Charter Platinum Member of CDISC, DATATRAK has a long history of supporting CDISC and its mission to define and implement standards industry-wide. The Company currently holds CDISC Registered Solution Provider (RSP) status in the following categories:


  • CDASH
  • Define.XML
  • LAB
  • Operational Data Model
  • Study Data Tabulation Model

About DATATRAK

DATATRAK is the leader of unified eClinical® technologies and related services for the clinical trials industry. Using the DATATRAK ONE multi-product, cloud-based clinical research platform, DATATRAK's Clinical and Consulting Services group assists clients in conducting Phase I-IV drug and device studies in multiple languages throughout the world. DATATRAK has offices located in Cleveland, Ohio; Bryan, Texas; and Cary (RTP), North Carolina. For more information, visit www.datatrak.net.

Except for the historical information contained in this press release, the statements made in this release are forward-looking statements. These forward-looking statements are made based on management's expectations, assumptions, estimates and current beliefs concerning the operations, future results and prospects of the Company and are subject to uncertainties and factors which are difficult to predict and, in many instances, are beyond the control of the Company, and which could cause actual results to differ materially from those contemplated in these forward-looking statements. For a list of certain factors that may cause actual results to differ materially from those contemplated in these forward looking statements, please see the Company's report filed with the OTCQX Market on November 14, 2012 announcing its results for the three-month period ending September 30, 2012. The Company undertakes no obligation to update publicly or revise any forward-looking statement whether as a result of new information, future events or otherwise.

SOURCE DATATRAK International, Inc.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES